We’re heading to #MDAconference to join the community advancing research, care, & education for #neuromuscular diseases & to connect with partners like @nordrare.bsky.social, GBS | CIDP, Blood Cancer United, & @aafanational.bsky.social
Stay tuned for details on our poster acceptance: bit.ly/4bca56N
A noteworthy highlight of #AAAAI26 was connecting with @aafanational.bsky.social 🌟 As longtime collaborators, we’re proud to advance patient-centered education in #asthma & #allergy care together, delivering education that empowers patients & strengthens clinical decision-making. 💜 bit.ly/478yEQC
The team is onsite at #AAAAI26 this week & what an incredible few days it’s been connecting with APFED, I-FPIES, NEA, @faactnews.bsky.social, & others. 👏 Conversations centered on patient needs, education gaps, & elevating evidence-based resources for all. Explore our collaborations: bit.ly/3OIxu8c
For clinicians treating NMIBC, tolerability drives success with intravesical therapy.
Get practical tips to prevent early AEs, manage challenges, and improve procedural technique.
👉 Access the program: bit.ly/46CiLlk
#HCPEducation #NMIBC #BladderCancer #Urology #Oncology
Its Rare Disease Day®! Yesterday at #RDDNIH, we shared outcomes from our #CME initiative on #RettSyndrome. In partnership with @nordrare.bsky.social & @rettsyndrome.bsky.social, we highlighted how patient-centered education supports clinicians across diagnosis, treatment, & care. 🔗 bit.ly/4snliIB
In the spirit of Rare Disease Day, save the date! We’re excited to support our partner @nordrare.bsky.social’s 2026 #NORDSymposium.
📅 April 14–15, 2026 📍 Arlington, VA
🔗 Join us in advancing care for rare diseases: nordscience.org
Every person with a rare disease deserves access to the right care, research, and support. We are proud to stand with our partner @nordrare.bsky.social to expand access to rare disease education.
Join us to create a future where no condition is too rare to matter: bit.ly/4rA6FRZ 💜✨🦓
On-site at #GU26, sharing insights on advancing first-line care in locally advanced/metastatic #urothelial #carcinoma! Developed with partners LUGPA & @bladdercancerus.bsky.social, this initiative blends clinician & patient advocacy perspectives to drive community-informed education. bit.ly/4rHAgcw
Today’s the day! We’re at #RDDNIH spotlighting how advocacy partnerships shape real-world, patient-centered education in #RareDiseases. Partnering with @nordrare.bsky.social + @rettsyndrome.bsky.social, this CME initiative brings real patient experiences into case-based learning. 🔗 bit.ly/4cen8Xp
We’re heading to #AAAAI26 to join the global community advancing care in #asthma, #allergy, & #immunology. Excited to connect with leaders, researchers, & partners like @aafanational.bsky.social & @nordrare.bsky.social who are shaping the future of patient-centered education. See you in Philly! 🌟
We’re heading to #GU26 to share insights on advancing care in la/mUC. In collaboration with LUGPA & @bladdercancerus.bsky.social, this initiative brings clinician + patient advocacy voices into a community-informed education strategy. 🔗 bit.ly/4rHlliy
@ascocancer.bsky.social
The average rare-disease patient waits years for a diagnosis, often seeing multiple specialists before receiving answers. It’s time to change that.
Join the Rare Disease CME Challenge with @nordrare.bsky.social to get started: bit.ly/4kVUgph
We are proud to launch the first Earn Your Stripes: Rare Disease CME Challenge exclusively in partnership with @nordrare.bsky.social improve the early identification, diagnosis, and management of rare conditions. Start earning your stripes now: bit.ly/4rDTyQ4
Now on demand: This expert-led #CME program explores modern HoFH management, including emerging LDL-C therapies and practical strategies to optimize care.
Watch now: bit.ly/4cu703X
#HoFH #CardiologyCME #LDLCManagement #MedicalEducation
We're presenting outcomes at #GU26! Sharing new insights on advancing first-line care in la/mUC, our poster reflects a collaborative effort with LUGPA & @bladdercancerus.bsky.social, bringing together clinical & patient perspectives. Details soon: bit.ly/4kJhhvc
@ascocancer.bsky.social
It’s been an energizing few days at #Alliance26, connecting with #CME partners and peers who are focused on measurable outcomes, scalable digital education, and patient-centered programming. To learn how Medlive supports outcomes-driven CME, visit 👉 tinyurl.com/42tw8cs5
@alliance4cehp.bsky.social
🌟 Poster session highlights from #Alliance26 in Atlanta where we shared our outcomes poster, featuring learnings informed by a multi-year, multi-program educational initiative with @aafanational.bsky.social. Thank you to everyone who stopped by!
Read more: bit.ly/4c0r3H9
@alliance4cehp.bsky.social
Join our expert-led #CME program on HoFH management. Explore new LDL-C therapies and case-based care strategies.
Register now: bit.ly/4cu703X
#HoFH #CardiologyCME #LDLCManagement #MedicalEducation
Explore current evidence and best practices for advanced/metastatic NSCLC in this expert-led discussion, and earn #CME.
Watch now ➡️ bit.ly/3LMAI9K
#MedicalEducation #LungCancer #NSCLC #PrecisionOncology
We're heading to #RDDNIH to share outcomes from a #CME initiative on #RettSyndrome, highlighting patient-centered & outcomes-driven design to help close gaps in #RareDisease care. 🌟
Stay tuned for poster details & explore rare disease programs here: bit.ly/3Mq3SM3
@nordrare.bsky.social & IRSF
Throwback to 1970 or #Alliance25? 👀 🕺 Excited to share that we'll be back at #Alliance26, sharing learnings from a multi-year, multi-program outcomes assessment across clinician + patient education. Read more: 🔗 bit.ly/4rzMVNY
@alliance4cehp.bsky.social @aafanational.bsky.social
Only ~20% of eligible patients receive CAR T therapy. Access shouldn’t depend on zip code. On #WorldCancerDay, take steps toward change for community-based care expansion.
Act now by watching the full CME program with our partners @aacicancer.bsky.social & @astct.bsky.social 👉 bit.ly/3Zx8Jhd
Kidney-sparing management in low-grade UTUC: what does 5-year follow-up show?
Experts review long-term outcomes and case-based approaches to recurrence and surveillance.
▶️ Access the program today: bit.ly/4kcoJ1L
#UTUC #UroOncology #KidneySparing #Urology #ClinicalPractice
AACI has partnered with @medliveofficial.bsky.social to share on-demand education on CAR T-cell therapy for non-Hodgkin lymphoma and multiple myeloma. Expert-led sessions cover referral pathways and management strategies for community practice.
Watch now: bit.ly/45eV1lV
Welcome, Dr. Hans Lee, MD, to the Advisory Board! As Director of Myeloma Research at SCRI, he leads innovative work advancing new therapeutic strategies through early-phase clinical trials. 🩺
His insight will help strengthen our #PatientCentered, video-first oncology education. 🔗 bit.ly/4rpCI6R
Are you up to date on care for Multifocal Motor Neuropathy (MMN)?
Join us live today at 2:00 PM ET for expert insights on diagnosis and emerging treatment options.
👉 Save your spot now: bit.ly/4c0ePy9
#MMN #Neurology #CME #MedicalEducation #ClinicalPractice
Honored to welcome Dr. Ghassan Abou-Alfa, MD, JD, MBA, PhD(hc) to the Advisory Board. As a Professor of Medicine & an Attending Physician at @mskcancercenter.bsky.social, he brings deep expertise in hepatobiliary cancers to our #PatientCentered digital education. 👏💡
Read more 🔗 bit.ly/4q9GPD4
New on-demand #CME explores type 2 inflammation and eosinophils in COPD, with practical guidance on personalizing care and emerging biologics.
Watch on demand 👉 bit.ly/4q5xTyx
#MedicalEducation #Pulmonology #COPD #EosinophilicCOPD #Type2Inflammation
Welcome Dr. Aaron Lisberg, MD, Assistant Professor of Clinical Medicine at UCLA, to the Medlive Advisory Board. 👏 A leader in #immunotherapy + thoracic #oncology, he’s partnered with us since 2020 to advance clinician + patient education in #CancerCare. Read more: bit.ly/3M7wf1l
We're heading to #Alliance26 to present outcomes from our patient-centered video-first education shaped by partners like @aafanational.bsky.social
Excited to join @alliance4cehp.bsky.social in celebrating 50 yrs of advancing continuing education, alongside fellow #CME leaders 🔗 bit.ly/45XLgcK
